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OBJECTIVES: This study compared radiofrequency ablation versus conventional surgery in patients who had not
undergone previous treatment for bilateral great saphenous vein insufficiency, with each patient serving as his
own control.
METHOD: This was a randomized controlled trial that included 18 patients and was carried out between
November 2013 and May 2015. Each of the lower limbs of each patient was randomly assigned to undergo
either radiofrequency ablation or conventional surgery. Clinical features (hyperpigmentation, hematoma,
aesthetics, pain, skin burn, nerve injury, and thrombophlebitis) were evaluated at one week, one month, and six
months postoperatively. Hemodynamic assessments (presence of resection or occlusion of the great saphenous
vein and recurrent reflux in the sapheno-femoral junction and in the great saphenous vein) were performed at
one month, six months, and 12 months postoperatively. The independent observer (a physician not involved in
the original operation), patient, and duplex ultrasonographer were not made aware of the treatment done in
each case. Clinicaltrials.gov: NCT02588911.
RESULTS: Among the clinical variables analyzed, only the aesthetic evaluation by the physicians was significant,
with radiofrequency ablation being considered better than conventional surgery (average, 0.91 points higher:
standard deviation: 0.31; 95% confidence interval: -1.51, -0.30; p=0.003). However, in our study, we observed
primary success rates of 80% for radiofrequency ablation and 100% for conventional surgery.
CONCLUSIONS: If the physician is not required to inform the patient as to the technique being performed, the
patient will not be able to identify the technique based on the signs and symptoms. Our study revealed that
both techniques led to high levels of patient satisfaction, but our results favor the choice of conventional
surgery over radiofrequency ablation, as patients who underwent conventional surgery had better
hemodynamic assessments.
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’ INTRODUCTION
Superficial venous insufficiency (VI), which affects mil-
lions of patients worldwide, is one of the most common
conditions observed by vascular surgeons in clinical practice.
The prevalence of superficial VI varies greatly and is highest
among Western populations, with varicose veins (CEAP 2)
being observed in 13% to 46% of women and 11% to 29% of
men (1,2). Superficial VI can cause leg fatigue, pain and swell-
ing and can lead to more serious complications such as deep
vein thrombosis (DVT) and stasis ulcers. Thrombophlebitis,
lipodermatosclerosis, and bleeding veins have also been
reported to be associated with superficial VI. Most cases of
varicose veins (70%) are due to sapheno-femoral junction
(SFJ) insufficiency and/or great saphenous vein (GSV) reflux.
The extent of saphenous vein reflux is directly correlated
with disease symptoms (3).
Due to its progressive nature, superficial VI can cause
increasingly debilitating symptoms as the patient ages,DOI: 10.6061/clinics/2016(11)06
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especially if left untreated. In addition to having a consider-
able impact on the patient’s quality of life, superficial VI is a
major public health concern, as it may result in the loss of
working days and high costs for the local health system (both
public and private) (4).
Treatment of superficial VI may be interventional or
supportive. Interventional treatments include the following:
1) conventional surgery (CS), 2) thermal ablation techniques
such as radiofrequency ablation (RFA) and endovenous laser
ablation (EVLA), and 3) ultrasound-guided foam sclerother-
apy (UGFS). Supportive treatments include compression
stockings (5-8). Interventional procedures can be performed
on an inpatient or outpatient basis, with the latter option
being associated with lower costs (9,10).
CS and thermal ablation approaches are considered the
best forms of treatment for this progressive disease. Until
recently, CS was the gold standard treatment for GSV insuf-
ficiency, with good initial success rates and low recurrence
rates in the short term (11,12). The more recently developed
thermal ablation techniques, such as RFA and EVLA, involve
catheter-based ablation of the GSV. Studies reporting the
safety of these techniques also reported higher recurrence
rates after endovenous techniques (13,14).
Postoperatively, variables such as recovery time, complica-
tions, aesthetic results, time away from work, and costs vary
among the reports, and whether RFA or EVLA is advanta-
geous relative to CS in terms of these variables is still con-
troversial (1).
A meta-analysis of 28 randomized controlled trials (RCTs)
revealed that primary failure and recurrence did not differ
significantly by technique (EVLA, RFA, and CS). However,
these thermal ablation techniques resulted in fewer hemato-
mas and wound infections, as well as less pain and a quicker
return to normal activities (15). This meta-analysis included
studies that allocated each patient to a different technique as
well as studies that applied more than one technique in a
single patient (one in each leg). In the only study that directly
compared RFA and CS in the same patient, the patients had
undergone a previous SFJ ligation that resulted in the
recurrence of GSV insufficiency (16).
In the current study, we conducted an RCT in which we
randomized the lower limbs of each patient to RFA or CS.
The patients had no history of previous treatment for bilat-
eral GSV insufficiency. Each leg was assessed for post-
operative symptoms and complications. In addition, duplex
ultrasound was used to evaluate the presence of resection or
occlusion of the GSV, as well as reflux in the SFJ and GSV. To
the best of our knowledge, no study to date has compared
RFA versus CS in patients who served as their own controls
and who had intact GSVs.
’ MATERIALS AND METHODS
The study was carried out in the Department of Vascular
Surgery of a secondary referral hospital between November
2013 and May 2015.
The inclusion and exclusion criteria are summarized
in Table 1. A total of 18 patients entered the trial, which
consisted of a randomized controlled study. According to the
protocol, each patient was treated with RFA on one leg and
CS on the contralateral limb. Randomization was performed
preoperatively using a randomization table. Patients were
not advised of the treatment allocation to ensure that this
trial was carried out in a blinded fashion. All operations were
performed under regional anesthesia administered via spinal
block by the same surgical team who was skilled in the
management of venous disease and had extensive expertise
in both techniques. Phlebectomy of varicosities and treat-
ment of incompetent perforating veins were not concomi-
tantly performed.
CS
Patients underwent a standard procedure of cranial
ligation of the GSV and branches of the SFJ using a groin
crease incision and stripping of the GSV from the SFJ to ankle
level using a vein stripper that was extracted through a small
incision near the medial malleolus.
RFA
The procedure was performed under ultrasound guidance.
The GSV proximal to the medial malleolus was cannulated
with a 7F sheath using the surgical cutdown approach. The
tip of the radiofrequency catheter was placed at least 2 cm
distal to the SFJ or just distal to the superficial epigastric
vein orifice. Patients received tumescent infiltration with
cold normal saline (0.9%) circumferentially around the GSV
within its enveloping fascia and along the entire length of the
treated vein; this was to prevent nerve injury and thermal
injury to the skin. Then, the catheter was slowly withdrawn
according to the device manufacturer’s recommendations.
Table 1 - Inclusion and exclusion criteria.
Inclusion criteria Exclusion criteria
 Age between 18 and 60 years
 Clinical, etiological, anatomical, pathophysiological (CEAP):
clinical grades 2 to 5 (C2-5), primary (Ep), superficial (As),
and reflux only (Pr)
 Primary bilateral GSV insufficiency requiring surgery and
confirmed by duplex scan (insufficiency with reverse venous
flow was regarded significant if persisting more than
0.5 seconds in a standing position)
 Suitability for radiofrequency ablation confirmed by duplex
scan (see exclusion criteria)
 Patients able to give informed consent
 Varicose veins without GSV insufficiency on duplex scan
 Previous varicose vein surgery
 Associated small saphenous vein reflux, duplication of the
GSV at the SFJ, deep venous insufficiency, or previous deep
vein thrombosis on duplex scan
 GSV diameter o3 mm or 412 mm in the supine position
 Thrombus in the GSV
 Patients with a pacemaker or internal defibrillator
 Concomitant peripheral arterial disease (ankle-brachial pressure
index of o0.9)
 Patients on oral anticoagulants
 Patients with high blood pressure not controlled by medication
 Patients with known thrombophilia, cancer or lupus
 Pregnancy
GSV, great saphenous vein; SFJ, sapheno-femoral junction.
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The technique consisted of controlled segmental heating of the
GSV using a catheter with a 7-cm heating element (Closuret
system, VNUSMedical Technologies, Inc., San Jose, California,
USA), followed by manual compression over the GSV. The
temperature was maintained at 120oC per segment for a
standard length of time. The temperature-controlled RFA con-
tinued until the catheter tip reached just below the knee.
Immediately following treatment with RFA, intraoperative
ultrasound imaging was used to confirm shrinkage of the vein.
To ensure that the independent observer, a physician who
was responsible for outcome assessment and not involved in
the original operation and the patient were not made aware
of the treatment performed in each case, a groin crease
incision and an incision proximal to the medial malleolus
were created on both legs. For limbs operated on using the
radiofrequency technique, a groin crease incision was made
similar to the contralateral side but with no manipulation of
the SFJ. The incision proximal to the medial malleolus was
used for sheath insertion.
Postoperatively, dressings were placed over the wounds
and the patients’ legs were wrapped in sterile absorbent
bandages and covered with a cohesive compression bandage
for 48 hours. Patients were instructed to immediately lie
down with their legs elevated and to walk for progressively
longer periods each day. After removal of the bandages,
patients were instructed to use 20- to 30-mmHg compression
stockings for four weeks. All patients were discharged on
the same day as the procedure and were encouraged to
resume work and normal activity as soon as they were able.
Analgesics and nonsteroidal anti-inflammatory drugs were
prescribed to the patients.
There were 18 patients (36 legs), including 11 women and
7 men. The average age was 48.1 years (range: 33-76;
standard deviation (SD): 12.7). The mean body mass index
was 28.1 kg/m2 (range: 22.4-34.9; SD: 3.5). There were no
diabetic patients; only three patients had a positive history of
smoking, and only six patients had high blood pressure.
For clinical assessments, patients were scheduled for
follow-up visits at one week, one month, and six months
after surgery. For duplex ultrasound scan assessments,
patients were scheduled for follow-up visits at one month,
six months, and 12 months after surgery. Twelve patients
were followed for up to one year and the remaining six
patients were followed for six months.
Each leg was assessed for postoperative symptoms and
complications by an independent observer, who was a
physician not involved in the original operation and by the
patient. The surgeons were not involved in the outcome
assessments. The clinical outcomes included intensity of
hyperpigmentation, extension of hematoma, aesthetic results,
pain levels, severity of skin burns, nerve injury, and throm-
bophlebitis. Patients and physicians were instructed to indicate
their subjective perception of hyperpigmentation and hemato-
mas on a scale of 0 (no complaint/discomfort) to 10 (maximal
complaint/discomfort) as well as aesthetic results on a scale of
0 (unaesthetic) to 10 (excellent results). Patients were also asked
to indicate their pain levels on a scale of 0 (no pain) to 10 (worst
imaginable pain) and to indicate any changes in sensitivity.
Physicians were also asked to indicate the severity of skin
burns on a scale of 0 (no skin burns) to 10 (severe skin burns)
and to report the presence of thrombophlebitis.
Duplex ultrasonography was used to evaluate the follow-
ing hemodynamic outcomes: the presence of resection or
occlusion (success rate) of the GSV and reflux in the SFJ and
GSV, as well as the presence of complications such as DVT
and lymphocele. The duplex ultrasonographer was not made
aware of the treatment performed on each side before
examining the leg.
Statistical analysis
Regarding demographic characteristics, the quantitative
variables are reported as the mean ± standard deviation,
and the categorical variables are reported as the absolute and
relative frequencies.
The hemodynamic outcomes are presented as the duplex
ultrasound scan findings and moments of evaluation using
absolute and relative frequencies. However, a statistical analysis
could not be performed because the sample size of 18 was
too small.
The clinical outcomes are described as types of technique
and moments of evaluation and are reported as the mean±
standard deviation. The variables were compared between
techniques and moments of evaluation using generalized
estimating equations with an exchangeable correlation matrix
and assuming a normal distribution with an identity link
function. For models with statistical significance, an additional
analysis using the Bonferroni multiple comparison test was
performed.
A probability value (p value) of less than 0.05 was consi-
dered statistically significant. The 95% confidence interval
(CI) was also included where appropriate.
For our analyses, we calculated three p values: one
corresponding to the technique across all three moments of
evaluation (ptechnique); one corresponding to the moment of
evaluation (which considered both techniques together,
pmoment); and one corresponding to the interaction between
technique and moment (pinteraction).
Ethics
Approval was obtained from the Local Research Ethics
Committee (Plataforma Brasil CAAE03772812.7.0000.0071),
and all patients provided written informed consent for
inclusion in the trial.
’ RESULTS
Hyperpigmentation, hematoma, pain, aesthetic percep-
tion, thrombophlebitis, nerve injury, and skin burns were
assessed after surgery. Of these variables, thrombophlebitis,
nerve injury, and skin burns exhibited null results. Subjec-
tive ratings for the first four variables are summarized in
Tables 2 and 3.
The subjective assessments conducted by patients and
physicians are presented in Table 2. The pinteraction result was
not statistically significant for any of the variables studied,
indicating that the difference between techniques (RFA and
CS) did not vary over time. The only variable that reached
significance when comparing both techniques was aesthetic
evaluation by physicians, which revealed that the RFA-
treated limb received, on average, an evaluation of 0.91
points higher (SD: 0.31; 95% CI: -1.51, -0.30; ptechnique=0.003)
than the conventionally treated side. At six months, the
physicians assigned 10 points each to all the limbs in the
aesthetic evaluation. There were significant differences
between the moments in both the physicians’ and patients’
evaluations of hematoma and aesthetics and in the patients’
evaluation of pain (pmoment).
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The comparisons between the different moments stud-
ied are presented in Table 3. For pmoment, we observed that
the perception of the extension of hematoma was lower
at one and six months compared to one week for both
physicians and patients (po0.001). However, the perception
at one month was not significantly different from that at
six months for either technique. For both techniques, the
aesthetic evaluation progressively improved over time
(po0.05). Finally, pain level progressively and significantly
decreased from one week to one month and six months
(po0.05).
There were no minor or major postoperative complica-
tions. Importantly, no cases of DVT were observed during
follow-up. All patients took less than one week to return to
work and used compression stockings for the recommended
length of time.
Immediate intra-operative success was reported in all
cases, with complete resection or occlusion of the GSV.
For limbs operated on using the conventional technique,
there were no cases of reflux in the SFJ and no cases of
segmental reflux at any time. For limbs operated on using the
radiofrequency technique, the closure rate improved over
time, but only 80% of the GSVs studied exhibited complete
obliteration after one year. Reflux involving the SFJ and GSV
was observed in one patient on the 30th day; however, this
resolved over time, as shown by the six-month duplex
ultrasound scan exam (Table 4).
’ DISCUSSION
Among the clinical variables analyzed, only the aesthetic
evaluation by physicians reached significance, with RFA
Table 2 - Subjective assessments conducted by patients and physicians of the surgical techniques over time.
Moment Conventional Surgery Radiofrequency Ablation ptechnique pmoment pinteraction
Mean±SD Mean±SD
Hyperpigmentation (physician) 1 week 0.00±0.00 0.00±0.00 0.644 0.179 0.802
1 month 0.24±0.97 0.12±0.49
6 months 0.00±0.00 0.00±0.00
Hyperpigmentation (patient) 1 week 0.00±0.00 0.00±0.00 0.348 0.403 0.403
1 month 0.47±1.94 0.00±0.00
6 months 0.00±0.00 0.00±0.00
Hematoma (physician) 1 week 4.86±2.93 4.21±3.07 0.194 o0.001 0.598
1 month 1.00±1.95 0.00±0.00
6 months 0.00±0.00 0.00±0.00
Hematoma (patient) 1 week 4.50±2.79 4.21±3.60 0.483 o0.001 0.837
1 month 0.45±1.04 0.00±0.00
6 months 0.00±0.00 0.00±0.00
Aesthetic evaluation (physician) 1 week 6.29±2.02 7.43±1.79 0.003 o0.001 0.089
1 month 7.27±1.79 8.82±1.47
6 months 10.00±0.00 10.00±0.00
Aesthetic evaluation (patient) 1 week 6.93±2.70 6.86±2.71 0.843 o0.001 0.936
1 month 7.45±3.88 7.82±3.03
6 months 10.00±0.00 10.00±0.00
Pain 1 week 5.64±3.80 3.71±3.27 0.060 o0.001 0.309
1 month 2.14±2.74 1.08±2.07
6 months 0.00±0.00 0.00±0.00
SD, standard deviation
For our analyses, we calculated three p values: one corresponding to the technique (ptechnique), one corresponding to the evaluation moment (pmoment),
and one corresponding to the interaction between technique and moment (pinteraction).
Table 3 - Comparison between the different moments studied for hematoma, aesthetic result, and pain.
Comparisons Mean difference±SD 95% CI p
Hematoma (physician) 1 week vs 1 month 4.16±0.56 2.83 to 5.49 o0.001
1 week vs 6 months 4.58±0.52 3.33 to 5.82 o0.001
1 month vs 6 months 0.42±0.55 -0.90 to 1.74 40.999
Hematoma (patient) 1 week vs 1 month 4.16±0.56 2.81 to 5.51 o0.001
1 week vs 6 months 4.36±0.53 3.10 to 5.62 o0.001
1 month vs 6 months 0.20±0.56 -1.15 to 1.54 40.999
Aesthetic evaluation (physician) 1 week vs 1 month -1.16±0.39 -2.09 to -0.22 0.009
1 week vs 6 months -3.13±0.36 -3.99 to -2.27 o0.001
1 month vs 6 months -1.97±0.38 -2.89 to -1.05 o0.001
Aesthetic evaluation (patient) 1 week vs 1 month -0.56±0.65 -2.10 to 0.99 40.999
1 week vs 6 months -3.07±0.59 -4.48 to -1.65 o0.001
1 month vs 6 months -2.51±0.63 -4.02 to -1.00 o0.001
Pain 1 week vs 1 month 3.06±0.66 1.48 to 4.64 o0.001
1 week vs 6 months 4.70±0.64 3.18 to 6.22 o0.001
1 month vs 6 months 1.64±0.65 0.08 to 3.19 0.035
CI, confidence interval; SD, standard deviation.
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being considered better than CS. On the other hand, CS had
better results due to its superior success rate.
For the patients, the aesthetic evaluation did not differ
by technique. This conclusion may reflect the fact that
physicians tend to overestimate the postoperative results, as
they have more experience in evaluating clinical outcomes,
whereas patients provide their perception based on their
personal life experiences.
Our study identified primary success rates of 80% for RFA
and 100% for CS. These rates are comparable to those in
previous reports (17-19).
Following CS, recurrence may be related to technical or
tactical failure, an incompetent below-knee GSV, neovascular-
ization leading to neoreflux in the groin, and new incompetent
perforators; however, considering RFA, recurrence may be
attributable to an incompetent below-knee GSV, disease
progression with neoreflux in the groin tributaries, and
recanalization of a previously occluded GSV (1).
In the present study, a groin incision without tissue dis-
section was made on limbs operated on using the radio-
frequency technique. Some authors have suggested that
patients undergoing RFA may be less prone to neovascular-
ization because the SFJ is left untouched (20). Neovascular-
ization is thought to be the consequence of angiogenesis
following tissue trauma due to surgical dissection, and it has
been implicated as the main cause of recurrence in several
studies (21,22). This is ultimately linked to the need for rein-
tervention, which is a cause of patient dissatisfaction with
the technique (23).
It has been suggested that the observed high recurrence
rates following CS are related to the technical inadequacy of
the initial procedure (24). A larger number of recurrences
has been associated with insufficiency in the below-knee
GSV after stripping of the GSV to the knee only (25). It has
been argued that the length of stripping should be dictated
by the length of the refluxing vein and not by concerns over
injury to the saphenous nerve (26). The superior success rate
reported for CS in our study can be explained by the fact that
we performed stripping of the GSV from the SFJ to the ankle
level. However, full-length stripping remains controversial.
Although the issues of recurrence and neovascularization
are important, our trial was not designed to study them in
depth. Furthermore, the sample size was too small to draw
definitive conclusions regarding the clinical results of
recanalized segments of the GSV.
The design of the present study to compare the two
different techniques in the same patient undergoing treat-
ment for GSV reflux has been used previously (27,28) but not
in patients without a history of previous treatment for
bilateral GSV insufficiency. In the only previous study that
directly compared RFA and CS in the same patient, 16
patients had undergone a previous SFJ ligation that resulted
in the recurrence of GSV insufficiency. In that study, the
authors observed that RFA treatment was faster and resulted
in less pain and bruising. The complete success rates were
81.2% and 87.5% for RFA and CS, respectively, as two GSVs
were partially stripped in the limbs operated on using CS.
The maximum follow-up was 12 months (16).
Most of the available trials compare different techniques
performed in different patients. For this reason, the results of
these studies cannot be directly compared to our results. RFA
has been shown to be superior to CS in terms of short-term
and medium-term outcomes such as pain, return to activities,
quality of life, and patient satisfaction (19,29). One RCT that
randomized patients to RFA or CS revealed that RFA was
more expensive, but it enabled patients to return to work one
week earlier than after CS; patients were followed up toward
the end of the first and fifth weeks after surgery (18). Another
study that compared RFA and CS showed that RFA was
more expensive, had a lower overall complication rate
(including pain and hematoma) and had a shorter post-
intervention hospital stay; the follow-up visits ranged from
six months to two years after intervention (17).
Our results indicated that regardless of the technique
performed, patients’ evaluations of hematoma, aesthetics,
and pain improved over time, indicating that the patients
were more satisfied at six months than at one week. In our
study, none of the patients developed DVT, thrombophlebi-
tis, nerve injury, or skin burns. Considering DVT, previous
studies reported comparable rates of 1% (30), 0% (31), and
0% (17). Neurological damage is among the most common
side effects of GSV stripping. Saphenous nerve injury occurs
in approximately 40% of cases of long stripping of the GSV
but with little significant morbidity (32).
The sham incision was part of the protocol design for the
express purpose of not allowing the patient or the observer
(physician) to be aware of the technique used on each limb.
From a methodological point of view, this was the only
viable approach to ensure real blinding. The body of
literature related to the issue of using a sham incision reveals
that it is considered ethical by many authors (33,34).
We emphasized to all of the patients that such a procedure
could be associated with minimal risks (as observed in our
study, in which there were no complications related to groin
incisions, which were only necessary to ensure scientific
accuracy) and would only be performed in those patients who
had agreed to the study and had signed the informed consent
form. Patients were given the option of not participating in the
research study and being treated with standard therapy.
As previously mentioned, our study received approval
from the Local Research Ethics Committee. The Local Research
Ethics Committee understood that there would be minimal
risks involved and that the patients were free to refuse to
participate in the research and to instead be treated with
standard therapy.
As the number of collateral veins and perforators may
vary significantly between one leg and the contralateral leg,
phlebectomy of varicosities and treatment of incompetent
Table 4 - For limbs operated on using the radiofrequency technique: the number of patients showing venous occlusion or reflux at
each of the time points studied as assessed by duplex ultrasound scan and the number of patients with each condition out of the total
number of patients assessed (%).
At day 30 At 6 months At 12 months
Complete occlusion of the great saphenous vein 13/17 (76.5) 12/15 (80.0) 8/10 (80.0)
Reflux in the sapheno-femoral junction 1/17 (5.9) 0/15 (0.0) 0/10 (0.0)
Reflux in the great saphenous vein 1/17 (5.9) 0/15 (0.0) 0/10 (0.0)
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perforating veins were not concomitantly performed to
avoid having an impact as a confounding variable on the
evaluation of the extension of hematoma and pain levels (35).
It is possible that lower limbs with more avulsions had more
bruising and pain.
In our study, it was not possible to analyze and compare
quality of life, return to normal activities, loss of productivity
due to sickness leave, detailed costs related to the type of
anesthesia used (local vs. regional), the choice of treatment
system (outpatient vs. inpatient), and the use of specialized
equipment, as both techniques were conducted in the same
individual.
Another limitation of our study was the loss to follow-up
over time, as an analysis of all variables in the complete
sample could have increased the statistical significance. Our
trial was not specifically designed to assess long-term out-
comes. Further follow-up will hopefully allow robust con-
clusions to be drawn.
The most significant aspect of our trial was the comparison
of CS and RFA using a study design in which the patients
served as their own controls. lf the physician is not required
to inform the patient as to the technique being performed, the
patient will not be able to identify the technique based on
the signs and symptoms. Our study revealed that both
techniques led to high levels of patient satisfaction, but our
results favor the choice of CS over RFA, as patients who
underwent CS had better hemodynamic assessments.
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